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Abstract 
Amino acid deprivation or supplementation can affect cellular and organismal lifespan, but we know 
little about the role of concentration changes in free, intracellular amino acids during aging. Here, 
we determine free amino-acid levels during chronological aging of non-dividing fission yeast cells. 
We compare wild-type with long-lived mutant cells that lack the Pka1 protein of the protein kinase A 
signalling pathway. In wild-type cells, total amino-acid levels decrease during aging, but much less so 
in pka1 mutants. Two amino acids strongly change as a function of age: glutamine decreases, 
especially in wild-type cells, while aspartate increases, especially in pka1 mutants. Supplementation 
of glutamine is sufficient to extend the chronological lifespan of wild-type but not of pka1Δ cells. 
Supplementation of aspartate, on the other hand, shortens the lifespan of pka1Δ but not of wild-
type cells. Our results raise the possibility that certain amino acids are biomarkers of aging, and their 
concentrations during aging can promote or limit cellular lifespan. 
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Introduction 
Dietary restriction extends lifespan and decreases age-related pathologies (1,2). These benefits may 
reflect protein or amino-acid restrictions rather than overall calorie intake (3,4). Restriction or 
supplementation of certain amino-acids affect lifespan from yeast to mouse (5). In budding yeast, 
isoleucine, threonine and valine extend the chronological lifespan (CLS, the time post-mitotic cells 
remain viable in stationary phase) (6). In other yeast strains, serine, threonine and valine decrease 
the CLS (7), while removal of asparagine extends the CLS (8). In mice, lifespan is extended by the 
branched chain amino acids (BCAAs: leucine, isoleucine and valine) (9), while in flies, limitation of 
BCAAs extends lifespan in a dietary-nitrogen-dependent manner (10). In mice, a tryptophan-
restricted diet extends lifespan (11), while a methionine-restricted diet extends lifespan and delays 
age-related phenotypes (12). In flies, methionine restriction extends lifespan (13). Similarly, in 
budding yeast, methionine restriction prolongs the CLS whilst methionine addition shortens it (14). A 
comprehensive analysis of amino-acid effects on lifespan has been undertaken in worms, where 
lifespan extends upon individual supplementation of 18 amino acids (15). These results indicate that 
amino acids can exert both pro- and anti-aging effects. In budding yeast, intracellular amino-acid 
content gradually decreases during chronological aging (16). What is missing, however, is a global 
quantitative analysis of intracellular amino acids in normal and long-lived cells during cellular aging.  
In fission yeast (Schizosaccharomyces pombe), the protein kinase A (PKA) glucose-sensing 
pathway promotes chronological aging but is not directly involved in amino-acid sensing or transport 
(19). Here we perform quantitative amino-acid profiling during aging in wild-type and long-lived 
pka1 mutant cells of S. pombe, which are deleted for the catalytic subunit of PKA. We show that 
intracellular amino-acid pools progressively decrease with age. This effect is less pronounced in long-
lived cells. Glutamine is depleted faster than the other amino acids, while aspartate increases during 
aging. Notably, supplementation of these two amino acids is sufficient to alter lifespan in wild-type 
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or pka1 mutant cells. Our results suggest both a correlative and causal relationship between 
longevity and intracellular amino acids. 
Results 
Quantitative amino-acid analysis during cellular aging 
We used liquid chromatography selective reaction monitoring (19) to quantify the free, intracellular 
pools for 19 of the 20 canonical proteogenic amino acids (cysteine was excluded as it is readily 
oxidized) during chronological aging of S. pombe wild-type and long-lived pka1Δ deletion-mutant 
cells. Cells were grown in minimal medium, because rich medium contains variable amounts of 
amino acids and cells accumulate intracellular amino acids when grown in rich medium (20). We 
collected cells from three independent biological experiments at three timepoints each: at Day 0, 
when cells enter stationary phase and both strains show 100% cell viability; at Day 5, when wild-type 
and pka1Δ strains show 50% and 87% viability, respectively; and at Day 8, when wild-type and pka1Δ 
strains show 20% and 50% viability, respectively (Figure 1A).  
We determined absolute concentrations of intracellular amino acids in nmol/6x107 cells 
(eTable 1). The amino-acid quantities, obtained from non-dividing cells, differed from those 
previously reported for fission yeast which have been obtained from rapidly proliferating cells 
(21,22). At the onset of stationary phase, the total amino-acid concentrations were lower in pka1Δ 
than in wild-type cells (Figure 1B). Accordingly, the individual amino-acid concentrations were lower 
or similar in pka1Δ than in wild-type cells at that stage (Figure 1C; Figure 2). The concentration 
differences were particularly pronounced for the BCAAs and aromatic amino acids (phenylalanine, 
tryptophan, tyrosine) (Figure 1C; Figure 2).  
During chronological aging, the concentration of total free amino acids declined in wild-type 
but less so in pka1Δ cells, even rising slightly at the last timepoint (Figure 1B). This rise primarily 
reflected an increase in the most abundant amino-acid, lysine, which compensated for the decline in 
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other amino acids (Figure 2). In wild-type samples, the variation in free amino acids between 
experimental repeats noticeably increased during aging, in contrast to pka1Δ samples (Figure 1B; 
Figure 2). This result raises the possibility that increased variation of amino-acid concentrations, 
reflecting less tight metabolic regulation, is a feature of wild-type aging cultures.  
Wild-type cells showed a general decrease in amino acids during aging, apart from aspartate 
(Figure 1C; Figure 2). The BCAAs were initially present at ~3-fold higher levels in wild-type cells 
before dropping to about half the level of pka1Δ cells (Figure 1C; Figure 2). No correlations were 
evident between aging-dependent concentration changes of amino acids and their chemical/physical 
features or metabolic pathways (Figure 1C). This result suggests that changes in amino-acid 
concentrations are not driven by limitation of precursor molecules. Likewise, there was no clustering 
based on glucogenic amino acids, which can be converted into glucose through gluconeogenesis 
(Figure 1C). This result suggests that any need for gluconeogenesis under glucose depletion does not 
greatly affect free amino-acid composition. Reassuringly, there was also no clustering based on 
membrane permeability (Figure 1C), as this suggests that the results were not biased by amino acids 
leaking from non-viable cells during the aging timecourse. 
Notably, the amino-acid profiles of wild-type and pka1Δ cells were similar overall at 
corresponding aging timepoints, when both strains showed 50% viability (Figure 1B,C; Figure 2). This 
result suggests that similar metabolic changes occur in aging wild-type and mutant cells, but that 
these changes are delayed in the long-lived mutant cells. Some amino acids, however, showed 
distinct patterns in wild-type and pka1 cells, including lysine, glutamate, glutamine and aspartate 
(Figure 1C; Figure 2). Glutamine and aspartate showed particularly striking profiles during aging. 
Glutamine rapidly and strongly decreased during aging, more pronounced in wild-type cells (Figure 
1C; Figure 2). Aspartate, on the other hand, was the only amino acid that increased during aging in 
wild-type cells, and this increase was more pronounced in pka1Δ cells (Figure 1C; Figure 2). These 
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results pointed to glutamine and aspartate as markers for aging in S. pombe and raised the 
possibility that these amino acids directly contribute to cellular lifespan.  
Glutamine supplementation extends lifespan of wild-type cells 
To examine the effect of glutamine on the CLS of wild-type and pka1 cells, we grew cultures to 
stationary phase in EMM2 minimal medium. During chronological aging, we replaced the medium 
with either EMM2 (control) on Day 1 or with EMM2 plus glutamine on either Day 1 (viability 84±8% 
for wild-type and 97±9% for pka1) or Day 5 (viability 50±6% for wild-type and 87±8% for pka1). 
These manipulations did not affect cell numbers or total protein levels of the aging cultures (eFigure 
1). In wild-type cells, glutamine supplementation significantly extended the CLS, both when added 
on Day 1 or 5 (Figure 3A,B). Glutamine supplementation at Day1 extended the medial CLS from 5 to 
6.5 days. Although Day 5 was close to the median lifespan of wild-type cells, glutamine still extended 
the CLS even at this late stage (Figure 3A,B). These results indicate that glutamine is beneficial for 
viability of aging wild-type cells. In pka1 cells, on the other hand, glutamine supplementation at 
either Day 1 or 5 had no effect on lifespan, with the median CLS remaining ~8 days (Figure 3C,D). We 
conclude that glutamine addition during cellular aging promotes longevity in wild-type cells, but not 
in the long-lived pka1 cells which maintain relatively higher glutamine levels during aging (Figure 
2).  
Aspartate supplementation shortens lifespan of pka1 cells 
To examine the effect of aspartate on the CLS of wild-type and pka1 cells, we performed the same 
experiment as with glutamine, but supplementing aspartate to chronologically aging cultures. Again, 
these manipulations did not affect cell numbers or total protein levels of the aging cultures (eFigure 
1). In wild-type cells, aspartate supplementation at either Day 1 or 5 had no effect on the CLS (Figure 
3E,F). In pka1 cells, on the other hand, aspartate led to a significant shorter CLS, both when applied 
on Day 1 or 5 (median CLS shortened from 8 to 6.7 or 7.7 days, respectively); however, the median 
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CLS remained longer than that of wild-type cells (Figure 3G,H). We conclude that aspartate addition 
during cellular aging has no effect in wild-type cells but shortens the CLS in pka1 cells where 
aspartate naturally strongly increases during aging (Figure 2).  
Discussion 
We report intracellular amino-acid concentrations in S. pombe as a function of both chronological 
aging and genetic background. Our results show an overall decrease in amino acids during 
chronological aging, especially in wild-type cells. Such a decrease has also been observed in budding 
yeast (16). We cannot exclude the possibility that some dead cells contributed to these amino-acid 
measurements, although amino acids with high membrane permeability do not increase with age 
and thus do not preferentially leak from dead cells. The amount and composition of most amino 
acids reflect the ‘biological age’ of wild-type and long-lived pka1 cells, being similar in cells of 
similar viability rather than similar chronological age. Hence, 5 day old wild-type cells feature a 
similar amino-acid signature as 8-day old pka1Δ cells, corresponding to the times when both strains 
show 50% viability. Such amino-acid signatures might therefore serve as aging biomarkers for S. 
pombe.  
Glutamine and aspartate show the most distinct profiles during aging, with a strong decrease 
of glutamine, especially in wild-type cells, and a strong increase of aspartate, especially in pka1Δ 
cells. The antagonistic changes in glutamine and aspartate are probably linked. During glucose 
deprivation, yeast cells turn to glutamine and glutamate for energy by making aspartate via 
glutaminolysis (23). Increased aspartate levels in aging pka1Δ cells could reflect that long-lived cells 
feature more efficient glutaminolysis, although alanine, another product of glutaminolysis, did not 
show the same trend. Induced glutaminolysis in long-lived cells could explain why aspartate did not 
increase lifespan in pka1Δ cells which naturally feature high aspartate levels.  
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Glutamine supplementation promotes longevity of wild-type but not of long-lived pka1Δ cells. 
Aspartate supplementation, on the other hand, shortens the lifespan of pka1Δ but not of wild-type 
cells. These amino acids also affect lifespan in worms (15): glutamine at high doses extends lifespan 
but at a lower dose shortens lifespan, while aspartate shortens lifespan. Glutamine and aspartate 
both affect mitochondrial functions which might mediate their lifespan effects. Glutamine, derived 
from the Krebs-cycle metabolite alpha-ketoglutarate, is one of the amino acids recently shown to 
become limited when blocking respiration in fermentatively growing S. pombe cells (21). Amino-acid 
supplementations at a later timepoint (Day 5) have weaker effects on longevity, likely reflecting the 
lower viability of the cell population at that time which diminishes any beneficial. It is actually 
surprising that the late supplementations, when cells are ageing, still have some effect on lifespan. 
Further experiments will provide mechanistic insights into the roles of glutamine and 
aspartate during aging. Our results suggest that decreased glutamine levels during aging not only 
correlate with aging in wild-type and pka1Δ cells but directly contribute to aging, which can be 
‘cured’ by glutamine addition in wild-type cells. These findings highlight the metabolic complexity of 
aging and its relationship with nutrient-sensing pathways like PKA. Interestingly, decreased 
glutamine levels are associated with aging also in budding yeast, rats and humans (16,24), suggesting 
that conserved cellular processes are involved in this phenomenon.  
Methods 
Strains and media 
Strain 972 h- was used as the reference wild-type. The pka1 deletion mutant (pka1::kanMX4 h-) was 
generated with standard methods (25). Strains were cultured in EMM2 minimal medium for mass 
spectrometry sample acquisition, chronological aging and amino-acid supplementation experiments. 
Liquid cultures were grown at 32°C with shaking at 170rpm.  
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Quantitative amino-acid profiling 
Amino-acid analysis was performed using hydrophilic interaction chromatography-tandem mass 
spectrometry (HILIC-MS/MS) as described (22). Cell numbers were determined with a Beckman Z-
series coulter counter to ensure equal cell amounts for extractions. The metabolites were extracted 
as described (22). Identification of 19 proteogenic amino acids was obtained by comparison of 
retention time and fragmentation patterns with commercial standards. Comparison against a 
standard curve produced from serial dilution of these standards allowed quantification of the free 
amino acids. The analysis was undertaken using an Agilent Infinity 1290 LC system with ACQUITY 
UPLC BEH amide columns (Waters Corporation, Manchester, UK) (pore diameter 130Å, particle size 
1.7μm, internal diameter 2.1, column length 100mm) coupled to an Agilent 6400 Series Triple 
Quadrupole LC/MS mass spectrometer operating in selected reaction monitoring mode. Cysteine 
was excluded from analysis due to its low stability. The co-eluting isomers threonine and 
homoserine were de-convolved using the homoserine-specific transition (m/z of 120->44). 
Amino acid supplementations 
Aging cells were incubated in media containing amino acid supplements at Days 1 and 5, by 
removing the supernatant after centrifugation (1000rpm, 3min) followed by resuspension in EMM2, 
EMM2 with 20mM glutamine, or EMM2 with 20mM aspartate up to their original culture volume. 
Amino acids were not directly added to medium because of solubility issues. Supplementation 
happened specifically on the designated timepoints and not throughout the chronological ageing. 
Chronological lifespan assays 
CLS assays were performed as described (17). Error bars represent standard deviations (of 9 
measurements), calculated from three independent cell cultures, with each culture measured three 
times at each timepoint. Areas under the curve (AUCs) were measured for all experimental repeats 
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with ImageJ (26). We compared AUCs for the portion of lifespan curve after amino-acids 
supplementation as before this time lifespan curves were identical.  
Total protein measurements 
We collected 10ml liquid cultures during exponential growth (OD600=0.5-1.0), the start of stationary 
phase (Day 0), and after amino-acid supplementation (Day 5). Cells were lysed using a Fastprep®-24 
(6.5m/s, 60sec) with addition of 300μl lysis buffer and 0.5 mm diameter glass beads. Protein 
concentrations were quantified by a Pierce™ BCA Protein Assay Kit following the manufacturer’s 
protocol, and absorbance values were obtained using the Magellan™ Data Analysis software. 
Proteins were separated in 4-12% Bis-Tris gel (NuPAGE®), and protein bands were detected using 
Ponceau S staining solution (Sigma, P7170).  
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Figure Legends 
Figure 1. Quantitative measurements of free, intracellular amino acids in chronologically aging 
cells.  A. CLS assays for wild-type and pka1Δ cells, performed in triplicate with each biological 
replicate measured in three technical repeats. Average lifespans are shown (solid lines) together 
with standard deviations (dotted lines). Hatched red lines indicate timepoints for amino-acid 
profiling.  B. Total amino-acid concentrations in wild-type and pka1Δ cells at different aging 
timepoints as indicated.  C. Heatmap showing quantitation of individual amino acids, along with 
known amino-acid properties at right. The log2 fold-change values relative to 100% viability of wild-
type cells (Day 0) were clustered using the R package pheatmap with standard settings. Averages of 
three timepoints with three independent biological repeats each are shown. 
Figure 2. Changing amino-acid concentrations during aging.  Normalised concentration values of 19 
amino acids in wild-type cells (left) and pka1Δ cells (right) during aging (top to bottom). For each 
condition, three independent samples were analysed. Concentrations are presented relative to 
mean value for given amino acid in wild-type cells at 100% viability (wt 100). Boxplots were created 
with R boxplot and default settings. Numbers next to strain at top of each graph represent % cell 
viability. 
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Figure 3. Effects of amino-acid supplementation on CLS.  A. CLS assays (average of three biological 
repeats with three technical repeats each) for wild-type cells with and without glutamine 
supplementation at Days 1 and 5 as indicated. Median CLS in control cells (horizontal orange line) 
and treated cells (dotted orange line) are shown.  B. Areas under curve (AUC) of CLS assays in A as 
indicated (left panel: AUCs from Day1, right panel: AUCs from Day 5). The p values (t-test) indicate 
significance of difference in CLS triggered by glutamine supplementation.  C. CLS assays as in A for 
pka1Δ cells with and without glutamine supplementation at Days 1 and 5.  D. AUC of CLS assays in C, 
as described in B.  E. CLS assays as in A for wild-type cells with and without aspartate 
supplementation at Days 1 and 5.  F. AUC of CLS assays in E, as described in B.  G. CLS assays as in A 
for pka1Δ cells with and without aspartate supplementation at Days 1 and 5.  H. AUC of CLS assays in 
G, as described in B. 
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